Advanced Search
Our Scientists
Prof. Manuel Peitsch

Manuel C. Peitsch, Prof.

Chief Scientific Officer

See Manuel's publications on PubMed

About Manuel 

As the Chief Science Officer at Philip Morris International, I am focused on the science behind Heated Tobacco Products and e-cigarettes to drive Tobacco Harm Reduction. I stand for scientific excellence, executed to the highest standards of quality as well as for scientific transparency and verification. 

I have many years of experience leading large multi-cultural research teams in systems biology and toxicology, scientific computing (bio- and chemo-informatics), text mining and molecular biology.

I hold several patents related to proteomics, genomics and scientific computing, and I’ve published over 250 articles, book chapters and technical reports. My publications have been cited over 27,000 times and I’ve done groundbreaking research into computational structural biology, text mining and systems toxicology. 

I founded two start-up companies, the [BC]2 conference, and the Swiss Institute of Bioinformatics, where I serve as the chairman of the board. 

Academically, I hold a BSc in Life Sciences, a MSc in Physical Chemistry and a PhD in Biochemistry, while I’m also an Adjunct Professor for Bioinformatics at the University of Basel.

Among the honors I’ve received are the New England Business and Technology Award and the UnitedDevices Grid Visionary Award. I’m also a ComputerWorld Honors Laureate.

Latest Publications

Show all
Title

Please succeed the reCAPTCHA challenge below.

Sorry an error occurs

Sorry an error occurs. Would you please retry to submit your question

Thanks

Thank you for getting in touch. We will get back to you as soon as possible. Your message will be vetted by our communications team to ensure the content is relevant before it is released to our employee.

PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.